Visionary Venture Fund

About The Fund

Visionary Venture Fund is a life sciences venture capital fund focused primarily on ophthalmology and medical aesthetics. Founded in 2016 and headquartered in Aliso Viejo, California, the fund deploys a unique information advantage strategy that involves connecting capital and insights with notable startups. They achieve this by leveraging partnerships with Key Opinion Leaders (KOLs), industry experts, and strategic acquirers. These thought leaders come from several fields and contribute insights and knowledge to help the fund source, vet, and support promising deals. Visionary Venture Fund specifically targets investments in early to late stages of a company's growth cycle, with an emphasis on Series A to commercialization phases. They seek to invest in visionary entrepreneurs with the potential to lead market-transformational businesses, particularly those focused on unmet or underserved markets, thereby funding impactful societal change. The fund's target investment sweet spot ranges from $5M to $15M, positioning them to play a significant role in catalyzing the growth of up-and-coming companies. Visionary Venture Fund is opportunistically involved in the economic impact of ophthalmic goods manufacturing on the Southern California economy and has been recognized for its active role in the healthcare sector by PWC Healthcare MoneyTree. The fund's portfolio includes companies that have achieved significant milestones, including strategic acquisitions by major players like Zeiss and Alcon. This fund is not just focused on financial returns but also on the broader value-adds such as clinical value assessment, strategic direction, and implementation resources, partnering with strategics that ensure assets are market-ready to serve more patients effectively.